You just read:

NeuroSigma Announces Presentation of Clinical Trial Data Showing Increased Brain Activity and Improved Cognition in Children with ADHD Treated with eTNS

News provided by

NeuroSigma, Inc.

Jun 27, 2019, 08:47 ET